Kathleen Tregoning

Insider Reports History

Location
C/O Cerevel Therapeutics Holdings, Inc., 131 Dartmouth Street Suite 502, Boston, MA
Signature
/s/ Maegan Deare, Attorney-in-Fact for Kathleen Tregoning
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathleen Tregoning:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Director Common Stock 75K $54.8K $0.73 Jun 12, 2025 Direct
Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer Stock Option (Right to Buy) 0 Aug 1, 2024 Direct

Insider Reports Filed by Kathleen Tregoning

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRO Spero Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 16, 2025 Director
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 3 $0 4 Aug 5, 2024 Chief Corporate Affairs Officer
SPRO Spero Therapeutics, Inc. May 29, 2024 1 $0 4 May 30, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jan 19, 2024 1 $0 4 Jan 23, 2024 Title: Chief Corporate Affairs Officer
SPRO Spero Therapeutics, Inc. Jan 2, 2024 1 $39.9K 4 Jan 4, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Dec 26, 2023 2 $31.7K 4 Dec 28, 2023 Title: Chief Corporate Affairs Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 19, 2023 3 -$260K 4 Dec 21, 2023 Title: Chief Corporate Affairs Officer
SPRO Spero Therapeutics, Inc. Oct 5, 2023 1 $0 4 Oct 10, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Feb 6, 2023 2 $0 4 Feb 8, 2023 Exhibit 24 - Power of Attorney. Officer title: Chief Corporate Affairs Officer
SPRO Spero Therapeutics, Inc. Jan 3, 2023 1 $39.9K 4 Jan 5, 2023 Director
SPRO Spero Therapeutics, Inc. Sep 15, 2022 1 $0 4 Sep 19, 2022 Director
CERE Cerevel Therapeutics Holdings, Inc. Feb 9, 2022 1 $0 4 Feb 11, 2022 Chief Corporate Affairs Officer
SPRO Spero Therapeutics, Inc. Jan 5, 2022 1 $40K 4 Jan 7, 2022 Director
SPRO Spero Therapeutics, Inc. Nov 11, 2021 1 $0 4 Nov 12, 2021 Director
SPRO Spero Therapeutics, Inc. Oct 11, 2021 0 $0 3 Oct 14, 2021 Director